Cellectis S.A. (CMVLF) Financials

Stock symbol CMVLF is outdated, potentially delisted? Maybe it is available on other exchange?

CMVLF Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2025	324.7 million	248.8 million
Sept. 30, 2025	343.0 million	242.6 million
June 30, 2025	354.0 million	256.9 million
March 31, 2025	364.1 million	247.9 million

CMVLF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2025	-11.1 million	?
Sept. 30, 2025	-2.8 million	1.6 million
June 30, 2025	-10.6 million	1.3 million
March 31, 2025	-17.6 million	976000

CMVLF Net Income

No data available :(

CMVLF Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2025	208.7 million	101.7 million	27.7 million
Sept. 30, 2025	190.2 million	79.0 million	37.6 million
June 30, 2025	196.2 million	81.8 million	39.7 million
March 31, 2025	241.7 million	78.9 million	41.0 million

CMVLF Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2025	?
Sept. 30, 2025	100.3 million
June 30, 2025	100.3 million
March 31, 2025	100.2 million

CMVLF Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2025	478475	24.7 million	4.8 million	-
Sept. 30, 2025	1.2 million	24.1 million	2.5 million	-
June 30, 2025	305000	23.1 million	2.3 million	-
March 31, 2025	395000	21.9 million	2.3 million	-

CMVLF Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2025	10.5 million	5.1 million
Sept. 30, 2025	35.2 million	2.4 million
June 30, 2025	16.7 million	2.4 million
March 31, 2025	10.7 million	2.0 million

CMVLF

Price: $4.50

52 week price:

1.25

5.04

Earnings Per Share: -0.67 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 452.7 million

Links:

CMVLF on Yahoo Finance